Procoagulant Extracellular Vesicles Alter Trophoblast Differentiation in Mice by a Thrombo-Inflammatory Mechanism.
Paulina MarkmeyerFranziska LochmannKunal Kumar SinghAnubhuti GuptaRuaa YounisKhurrum ShahzadRonald BiemannHanna HuebnerMatthias RuebnerBerend IsermannShrey KohliPublished in: International journal of molecular sciences (2021)
Procoagulant extracellular vesicles (EV) and platelet activation have been associated with gestational vascular complications. EV-induced platelet-mediated placental inflammasome activation has been shown to cause preeclampsia-like symptoms in mice. However, the effect of EV-mediated placental thrombo-inflammation on trophoblast differentiation remains unknown. Here, we identify that the EV-induced thrombo-inflammatory pathway modulates trophoblast morphology and differentiation. EVs and platelets reduce syncytiotrophoblast differentiation while increasing giant trophoblast and spongiotrophoblast including the glycogen-rich cells. These effects are platelet-dependent and mediated by the NLRP3 inflammasome. In humans, inflammasome activation was negatively correlated with trophoblast differentiation marker GCM1 and positively correlated with blood pressure. These data identify a crucial role of EV-induced placental thrombo-inflammation on altering trophoblast differentiation and suggest platelet activation or inflammasome activation as a therapeutic target in order to achieve successful placentation.
Keyphrases
- oxidative stress
- blood pressure
- diabetic rats
- high glucose
- nlrp inflammasome
- drug induced
- induced apoptosis
- physical activity
- weight gain
- metabolic syndrome
- early onset
- body mass index
- adipose tissue
- insulin resistance
- risk factors
- depressive symptoms
- heart rate
- blood glucose
- data analysis
- rare case
- artificial intelligence
- cell cycle arrest
- preterm birth
- red blood cell